Deep Track Capital, LP Pyxis Oncology, Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,184,100 shares of PYXS stock, worth $13.8 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
4,184,100Holding current value
$13.8 Million% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
76Shares Held
23.5MCall Options Held
88.6KPut Options Held
47K-
Laurion Capital Management LP New York, NY3.86MShares$12.8 Million0.14% of portfolio
-
Balyasny Asset Management LLC Chicago, IL2.59MShares$8.59 Million0.02% of portfolio
-
Stem Point Capital LP New York, NY1.79MShares$5.94 Million2.02% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.66MShares$5.5 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$4.64 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $116M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...